alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 88, Number 186 (Wednesday, September 27, 2023)]
[Notices]
[Pages 66437-66438]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21107]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 6115-000]


Pyrites Hydro, LLC; Notice of Authorization for Continued Project 
Operation

    The license for the Pyrites Hydroelectric Project No. 6115 was 
issued for a period ending August 31, 2023.
    Section 15(a)(1) of the FPA, 16 U.S.C. 808(a)(1), requires the 
Commission, at the expiration of a license term, to issue from year-to-
year an annual license to the then licensee(s) under the terms and 
conditions of the prior license until a new license is issued, or the 
project is otherwise disposed of as provided in section 15 or any other 
applicable section of the FPA. If the project's prior license waived 
the applicability of section 15 of the FPA, then, based on section 9(b) 
of the Administrative Procedure Act, 5 U.S.C. 558(c), and as set forth 
at 18 CFR 16.21(a), if the licensee of such project has filed an 
application for a subsequent license, the licensee may continue to 
operate the project in accordance with the terms and conditions of the 
license after the minor or minor part license expires, until the 
Commission acts on its application. If the licensee of such a project 
has not filed an application for a subsequent license, then it may be 
required, pursuant to 18 CFR 16.21(b), to continue project operations 
until the Commission issues someone else a license for the project or 
otherwise orders disposition of the project.
    If the project is subject to section 15 of the FPA, notice is 
hereby given that an annual license for Project No. 6115 is issued to 
Pyrites Hydro, LLC for a period effective September 1, 2023, through 
August 31, 2024, or until the issuance of a new license for the project 
or other disposition under the FPA, whichever comes first. If issuance 
of a new license (or other disposition) does not take place on or 
before August 31, 2024, notice is hereby given that, pursuant to 18 CFR 
16.18(c), an annual license under section 15(a)(1) of the FPA is 
renewed automatically without further order or notice by the 
Commission, unless the Commission orders otherwise.
    If the project is not subject to section 15 of the FPA, notice is 
hereby given that Pyrites Hydro, LLC is authorized to continue 
operation of the Pyrites Hydroelectric Project under the terms and 
conditions of the prior license until the issuance of a subsequent 
license for

[[Page 66438]]

the project or other disposition under the FPA, whichever comes first.

    Dated: September 21, 2023.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2023-21107 Filed 9-26-23; 8:45 am]
BILLING CODE 6717-01-P
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsCassini/Titan-4 Acoustic Blanket Development and TestingNASA Lewis Research Center recently led a multi-organizational effort to develop and test verify new acoustic blankets. These blankets support NASA's goal in reducing the Titan-4 payload fairing internal acoustic environment to allowable levels for the Cassini spacecraft. To accomplish this goal a two phase acoustic test program was utilized. Phase One consisted of testing numerous blanket designs in a flat panel configuration. Phase Two consisted of testing the most promising designs out of Phase One in a full scale cylindrical payload fairing. This paper will summarize this highly successful test program by providing the rationale and results for each test phase, the impacts of this testing on the Cassini mission, as well as providing some general information on blanket designs.Document ID19960047134Acquisition SourceLegacy CDMSDocument TypeConference PaperAuthorsHughes, William O.*(NASA Lewis Research Center Cleveland, OH United States)*McNelis, Anne M.*(NASA Lewis Research Center Cleveland, OH United States)*Date AcquiredSeptember 6, 2013Publication DateJuly 1, 1996Subject CategoryLaunch Vehicles And Space VehiclesReport/Patent NumberNASA-TM-107266NAS 1.15:107266E-10331Meeting InformationMeeting: Annual Technical Meeting and ExpositionLocation: Orlando, FLCountry: United StatesStart Date: May 12, 1996End Date: May 16, 1996Sponsors:Institute of Environmental SciencesAccession Number96N32897Funding Number(s)PROJECT: RTOP 256-00-00Distribution LimitsPublicCopyrightWork of the US Gov. Public Use Permitted.Available DownloadsNameType19960047134.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsThere are no records associated with this record.visibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
From: pauljw@aol.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 4:32:58 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Paul White

Saint Columbans, NE 68056
EXHIBIT 23.4

 

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

  We hereby consent to the incorporation    by reference in this Registration Statement on Form S-3 (No. 333-122288)    of CIT Funding Company, LLC of our report dated March 23, 2009 relating to    Dell Financial Services L.L.C.'s and its subsidiary, DFS-SVP L.L.C.'s Certification    Regarding Assessment of Compliance with Applicable Servicing Criteria Pursuant    to Item 1122 of Regulation AB, which appears as an exhibit to this Form 10-K.

/s/ PricewaterhouseCoopers LLPMarch 23, 2009New York, NY

 

-15-

----
From: angelwings42@gmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 4:46:02 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Denise Scarpuzzi

Fort Myers, FL 33905
|   | (1) | The      Report fully complies with the requirements of Section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the Company      as of and for the period covered by theReport. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | /s/ Larry W. Myers                               |
|--------|--------------------------------------------------|
|   | Larry      W. Myers                              |
|   | President      and Chief Executive Officer       |
|   | (principal      executive officer)               |
|   |                                             |
|   | /s/ Anthony A. Schoen                            |
|   | Anthony      A. Schoen                           |
|   | Chief      Financial Officer                     |
|   | (principal      financial and accountingofficer) |

----
(a)
    
    Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material
information relating to the registrant, including its
consolidated subsidiaries, is made known to us by
others within those entities, particularly during the
period in which this report is being prepared;(b)
    
    Designed such internal control over financial
reporting, or caused such internal control over
financial reporting to be designed under our
supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the
preparation of financial statements for external
purposes in accordance with generally accepted
accounting principles;(c)
    
    Evaluated the effectiveness of the registrants
disclosure controls and procedures and presented in
this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end
of the period covered by this report based on such
evaluation; and(d)
    
    Disclosed in this report any change in the registrants
internal control over financial reporting that occurred
during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an
annual report) that has materially affected, or is
reasonably likely to materially affect, the
registrants internal control over financial reporting;
and
  (a)
    
    All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; and(b)
    
    Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrants internal
control over financial reporting.
 Date: March 31, 2011
    By:
    /s/ Nigel JamesNigel JamesPresident and Principal Executive Officer 63
No. 64529.

#### Hat Corp. of America *v.*United States,

protests 59/27840, etc. (New York).

Opinion by

Hoed, J.

In accordance with stipulation of counsel that the merchandise consists of straw hats similar in all material aspects to those the subject of *Pollak Industrial Corp. et al.*v. *United States*(40 Cust. Ct. 251, C.D. 1991), the claim *of the*plaintiff was sustained.
Exhibit 10.37



 Exhibit 10.37 
 *** Text Omitted and Filed Separately 
 Confidential Treatment Requested

 Under 17 CFR §§ 200.80(b)(4) and 230.406 

2012 Corporate Goals for Strategic Leadership Team 
 Approved by the Compensation Committee on February 7, 2012 
 Revenue Growth versus Prior
Year (60%) 
  

					
	 Total Revenue Growth Vs. Prior Year
	  	Funding*	 
	 3 [***]% growth
	  	 	200	% 
	 3 [***]% growth
	  	 	175	% 
	 3 [***]% growth
	  	 	150	% 
	 3 [***]% growth
	  	 	125	% 
	 3 [***]% ([***])
	  	 	100	% 
	 3 [***]% growth ([***])
	  	 	50	% 
	 3 [***]% growth
	  	 	25	% 
	 £ [***]% growth
	  	 	No Payout	  

  

	*	Subject to a cash override: must maintain cash above 95% of year-end cash budget—otherwise the achieved revenue payout ($) will be discounted by 20%.


 Vantera Clearance and Launch (30%) 
  

	 	•	 	 Q2: CLIA registration of Vantera (10% weighting) 


  

	 	•	 	 Q2: Internal launch of Vantera for use in reporting clinical commercial results (20% weighting) 



 

	 	•	 	 Q3: FDA clearance (50% weighting) 


  

	 	•	 	 Q4: [***] initial satisfaction levels support positive external references (20% weighting) 



For purposes of these metrics, Q2, Q3, and Q4 are defined as the last day of each respective quarter. 

Furthermore, for each component a 10% increase/decrease in bonus will be applied for beating/missing the timeline goal by 30 days, 20%
increase/decrease for 31 to 60 days, 25% increase/decrease for 61 to 90 days. The bonus amount will be at the discretion of the compensation committee for any overachievement or delay greater than 91 days. 

If Vantera is not FDA approved in 2012, the entire Vantera payout will be zero. 
 Third Component: Successful IPO (10%) 
 While the Board is evaluating several pathways to
ensure that the company is adequately capitalized, the IPO is the clear preference, and this component reflects that desired outcome. 
 The
exact determination of whether the IPO was a successful IPO will be decided by the Board Compensation Committee in consultation with the Pricing Committee following completion of the IPO. 

 

	[***]	Certain confidential information in this document, marked by bracketed asterisks, has been omitted and filed separately with the Securities and Exchange Commission
pursuant to Rule 406 promulgated under the Securities Act of 1933, as amended. Confidential treatment has been requested with respect to the omitted portions.
NO. 07-08-0183-CR

IN THE COURT OF APPEALS

FOR THE SEVENTH DISTRICT OF TEXAS

AT AMARILLO

PANEL B

MAY 30, 2008

______________________________

MARY L. REYES,

Appellant

v.

THE STATE OF TEXAS,

Appellee

_________________________________

FROM THE 140th DISTRICT COURT OF LUBBOCK COUNTY;

NO. 2006-413009; HON. JIM BOB DARNELL, PRESIDING

_______________________________

Order of Dismissal

_______________________________

Before QUINN, C.J., and CAMPBELL and HANCOCK, JJ.

Mary L. Reyes, appellant, attempts to appeal her conviction for driving while

intoxicated with a passenger under fifteen years of age. The court imposed sentence on

January 18, 2008. Appellant then filed a motion for new trial on February 14, 2008. Her

notice of appeal was filed on April 18, 2008. We dismiss for want of jurisdiction.

To be timely, a notice of appeal must be filed within 30 days after the sentence is

imposed or suspended in open court or within 90 days after that date if a motion for new
The appropriate vehicle for seeking an out-of-time appeal from a final felony conviction is by writ of 1

habeas corpus pursuant to Article 11.07 of the Texas Code of Criminal Procedure. See TEX. CODE CRIM.

PROC. ANN. art. 11.07 (Vernon 2005).

2

trial is filed. TEX. R. APP. P. 26.2(a). A motion for new trial having been filed, appellant's

notice of appeal was due to be filed on or before April 17, 2008. Appellant’s attorney was

notified by this court on May 16, 2008, that the notice of appeal appears untimely and

directed him to file any documents or matters considered necessary for this court to

determine its appellate jurisdiction. These documents were to be filed no later than May

27, 2008. No documents or response have been received by the court to date. 

A timely filed notice of appeal is essential to invoke our appellate jurisdiction. Olivo

v. State, 918 S.W.2d 519, 522 (Tex. Crim. App. 1996). If it is untimely, we can take no

action other than to dismiss the proceeding. Id. at 523. Appellant's notice being untimely

filed, we have no jurisdiction over the matter and dismiss the appeal.

Accordingly, appellant’s appeal is dismissed.1

Brian Quinn 

 Chief Justice 

Do not publish.
#### UNITED STATES of America, Plaintiff-Appellee, v. James Gerald BOEH, Defendant-Appellant.

No. 00-10377.

D.C. Nos. CR 89-00619 EJG, CR 99-00425 EJG.

United States Court of Appeals, Ninth Circuit.

Argued and Submitted May 18, 2001.

Decided July 11, 2001.

Before HUG and T.G. NELSON, Circuit Judges, and PREGERSON,* District Judge.

*

 The Honorable Dean D. Pregerson, United States District Judge for the Central District of California, sitting by designation.

MEMORANDUM **

We have jurisdiction under 28 U.S.C. § 1291 and 18 U.S.C. § 3742, and we affirm.

We review a district court’s decision to revoke a term of supervised release for an abuse of discretion.1 The district court abuses its discretion where the record contains no evidence to support its decision,2 or where it rests its decision on a clearly erroneous finding of material fact.3

The district court determined that the amount of heroin in James Gerald Boeh’s (“Boeh”) possession was sufficient for usage. Further, based on relevant, admissible evidence, the district court found that the totality of the circumstances supported the inference that Boeh intended to distribute the heroin he possessed. The district court did not abuse its discretion in reaching these conclusions. Giving proper deference to the district court’s findings, we affirm the district court’s determination that Boeh possessed heroin with the intent to distribute, and affirm the resulting 51-month sentence.

AFFIRMED.

**

 This disposition is not appropriate for publication and may not be cited *to or by the*courts of this circuit except as may be provided by Ninth Circuit Rule 36-3.

1

. *See United States v. Musa,*220 F.3d 1096, 1100 (9th Cir.), *cert. denied,*531 U.S. 999, 121 S.Ct. 498, 148 L.Ed.2d 469 (2000); *United States v. Schmidt,*99 F.3d 315, 320 (9th Cir.1996) (citing *United States v. Laughlin,*933 F.2d 786, 788 (9th Cir.1991)).

2

. *Schmidt,*99 F.3d at 320.

3

. *United States v. Sprague,*135 F.3d 1301, 1304 (9th Cir.1998).
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

**FORM 8-K**

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): September 16, 2005

 

 

**FIRST NATIONAL LINCOLN CORPORATION**

(Exact name of Registrant as specified in charter)

 

MAINE

(State or other jurisdiction of incorporation)

 

0-26589 01-0404322

(Commission file number) (IRS employer identification no.)

 

Main Street, Damariscotta, Maine 04853

(Address of principal executive offices) (Zip Code)

 

(207) 563-3195

(Registrant's telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is

intended to simultaneously satisfy the filing obligations

of the registrant under any of the following provisions:

 

[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

 

 

 

 

 

 

TABLE OF CONTENTS

 

| Item 8.01 Other Events | Page 1 |
|------------------------|--------|

 

| Item 9.01 Financial Statements and Exhibits. | Page 1 |
|----------------------------------------------|--------|

 

| Signatures | Page 2 |
|------------|--------|

 

| Exhibit Index | Page 3 |
|---------------|--------|

 

 

 

 

 

Section 8 - Other Events

 

Item 8.01 Other Events.

 

On September 16, 2005, the Registrant issued the press release filed herewith as Exhibit 99.1 

announcing the declaration of a cash dividend.

 

Section 9 - Financial Statements and Exhibits

 

Item 9.01 Financial Statements, Pro Forma Financial Information and Exhibits.

 

(c) Exhibits.

--------

 

The following Exhibits are being furnished herewith:

 

99.1 Registrant's Press Release dated September 16, 2005.

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the

Registrant has duly caused this report to be signed on its behalf by the

undersigned hereunto duly authorized.

 

 

FIRST NATIONAL LINCOLN CORPORATION

 

By: /s/ F. STEPHEN WARD

---------------------

F. Stephen Ward

Executive Vice President & 

Chief Financial Officer

 

Dated: September 16, 2005

 

 

 

 

 

Exhibit Index

-------------

 

Exhibit

Number Description of Exhibit

------ ----------------------

 

99.1 Registrant's Press Release dated September 16, 2005.
EXHIBIT 13.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection
with the Annual Report on Form 20-F of Safe Bulkers, Inc. (the Company) for
the fiscal year ending December 31, 2008 as filed with the Securities and
Exchange Commission on the date hereof (the Report), the undersigned officer
of the Company certifies pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. the Report
fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

2. the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company as of, and
for, the periods presented in the report.

The foregoing
certification is provided solely for purposes of complying with the provisions
of Section 906 of the Sarbanes-Oxley Act of 2002 and is not intended to be used
or relied upon for any other purpose.

Date:  May 18, 2009

| |                                      | 
| | ------------------------------------ | 
| | /s/ POLYS HAJIOANNOU                 | 
| | Polys Hajioannou                     | 
| | Chairman and Chief Executive Officer | 
| | (Principal Executive Officer)        | 

Exhibit 13.1

---